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I stay at home with headache. A survey
to investigate how the lockdown for
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Abstract
Objective: The present Italian multicenter study aimed at investigating whether the course of primary headache
disorders in children and adolescents was changed during the lockdown necessary to contain the COVID-19 emergency
in Italy.
Methods: During the lockdown, we submitted an online questionnaire to patients already diagnosed with primary
headache disorders. Questions explored the course of headache, daily habits, psychological factors related to COVID-
19, general mood and school stress. Answers were transformed into data for statistical analysis. Through a bivariate
analysis, the main variables affecting the subjective trend of headache, and intensity and frequency of the attacks were
selected. The significant variables were then used for the multivariate analysis.
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Results: We collected the answers of 707 patients. In the multivariate analysis, we found that reduction of school effort
and anxiety was the main factor explaining the improvement in the subjective trend of headache and the intensity and
frequency of the attacks (p< 0.001). The greater the severity of headache, the larger was the clinical improvement
(p< 0.001). Disease duration was negatively associated with the improvement (p< 0.001). It is noteworthy that clinical
improvement was independent of prophylaxis (p> 0.05), presence of chronic headache disorders (p> 0.05) and geo-
graphical area (p> 0.05).
Conclusions: Our study showed that lifestyle modification represents the main factor impacting the course of primary
headache disorders in children and adolescents. In particular, reduction in school-related stress during the lockdown
was the main factor explaining the general headache improvement in our population.
Keywords
Migraine, COVID-19, lockdown, lifestyle
Date received: 17 June 2020; revised: 2 September 2020; 16 September 2020; accepted: 17 September 2020
Introduction
On 30 January, the Italian National Institute of Health
confirmed the first two cases of COVID-19 infection in
Italy. The infection spread to our country, especially
in the North, but it involved also other regions.
For this reason, on 4 March the government ordered
the closure of schools and universities throughout Italy,
while on 8 March Lombardy and other provinces of
northern Italy became isolated “red zones”. On 10
March, the Italian Prime Minister announced that the
restriction measures were to be extended to the whole
country. According to the new rules, summed up in the
hashtag #istayathome (#iorestoacasa in Italian), people
could go out of their home only for proven necessity
(the so-called ‘lockdown’). Lockdown measures had
significant economic, health and lifestyle implications.
As for children and adolescents, an important change
was the interruption of school activities with the start
of online lessons.
Several studies have emphasized the role of different
risk factors for migraine in children (1,2).
Dysfunctional family situation, school stress, anxiety,
and insufficient leisure time have been associated with
migraine onset and severity (3). In children, migraine
tends to have a seasonal trend during the year, proba-
bly in relationship to school attendance with an
increased risk of chronification in the winter months,
when school activities are intensified (4).
The COVID-19 pandemic was a global emergency
that generated both individual and collective psycho-
logical reactions and a source of stress (5) that could
affect children with primary headache diseases (6).
From this point of view, lockdown represented an
extreme condition in which the effect of different envi-
ronmental factors and stressful conditions on headache
disorders could be emerging.
The present multicenter study aimed at investigating
how children and adolescents with primary headache
disorders were affected by stress and lifestyle changes
secondary to the COVID-19 lockdown.
Methods
Subject recruitment
The multicenter study is based on the administration of
an online questionnaire to patients, aged between 5 and
18 years (scholar age), and their parents. Patients were
recruited from nine pediatric headache centers scattered
throughout the Italian national territory (Figure 1).
Patients were selected from the centers’ telephone
books and mailing lists. Only patients with a diagnosis
of migraine, with or without aura, or tension-type head-
ache according to the ICHD-3 criteria (7) were included.
Patients with other primary headache disorders, such as
paroxysmal migraine and cluster headache, were exclud-
ed. Moreover, included patients had to have a headache
history of at least 1 year and have visited the referral
headache center in the last 6 months.
Since prophylaxis medications typically have a latency
of about 3 weeks before they can take effect, only thera-
pies that started from 3 months to 3 weeks before the
compilation of the diary were considered as potentially
effective. Similarly, a possible headache worsening fol-
lowing a recent discontinuation of a prophylactic drug
was considered only if the drug had been interrupted in
the 4 weeks prior to completing the questionnaire.
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Patients who reported a frequency equal to or greater
than 15 attacks per month in the 2 months prior to the
lockdown were diagnosed as having possible chronic
migraine or chronic tension-type headache according to
the ICHD3 criteria (7). Taking into account the average
of “headache attack frequency before lockdown” and
“monthly assumption of drugs for the attack before lock-
down”, we built a synthetic “headache severity” index.
Towns of residence of patients have been grouped
according to the macro-areas “North”, “Center”,
“South and islands”.
Parents were asked for informed consent as well as
subjects over the age of 14 were asked to give their
consent. For patients under the age of 14, an assent
was requested for the completion of the survey. The
study was approved by the local Ethics Committee of
the Bambino GesuChildren’s Hospital. The design of
the study is shown in Figure 2.
Questionnaire structure
The link to the questionnaire was sent to the patients’
families via email or via mobile phone. The question-
naire remained available online from 27 March to 20
April. The trend of infections and deaths for COVID-
19 during this period is shown in Figure 1 (8).
Questions were sorted to allow a gradual transition
across eight topics. Some topics were explored both
with questions addressed to patients and their parents.
In the questionnaire, the pre-lockdown period referred
to the previous 2 months of January and February
2020. The topics are summarized below: i)
Demographic features; ii) lockdown information; iii)
features of headache ((a) duration of headache from
the first attacks; (b) type of headache disorder
according to diagnosis received by the reference head-
ache center; (c) a general judgment on the “trend of the
headache” during the lockdown; (d) variation in the
intensity of the attacks; and (e) the number of attacks
per month in the 2 months before the lockdown and
during the lockdown); iv) therapy for headache, includ-
ing drugs for attacks and prophylaxis; v) anxiety about
COVID-19; vi) general mood (anxiety and depressed
mood) (9,10); vii) school anxiety and viii) positive
coping abilities (for more details see Supplemental
material and Table 1).
Statistical analysis
The statistical analysis of data was conducted using the
open source software R and the suite RStudio. Subjects
who did not provide consent to data collection and
those whose answers were not analyzable were exclud-
ed from statistical analysis.
For the primary objective of analyzing the variation
in headache during the lockdown, we considered three
primary endpoints. The first primary endpoint was the
personal opinion that the subject expressed on the
trend of the headache, which could be improved,
stable or worsened (trend of headache). The second
primary endpoint was the subjective judgment on the
variation in the intensity of the attacks, which could be
increased, stable or reduced (intensity). The third pri-
mary endpoint was the ratio between the frequency of
monthly attacks during the lockdown and in the 2
months before the lockdown (frequency).
The first secondary objective was to analyze whether
there were differences in trend of headache, and inten-
sity and frequency of attacks between subgroups
(patients undergoing prophylaxis and not, chronic
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Figure 1. (a) Trend of infections for COVID-19 in Italy during the period of submission of questionnaire (blue line). (b) Geographical
distribution of deaths for COVID-19. Asterisks show the locations of the headache centers participating in the study.
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and non-chronic patients, and patients from different
geographical areas). The second secondary objective
was to verify whether the primary endpoints were influ-
enced by psychological aspects (school anxiety, general
anxiety, depression, COVID-19 anxiety); the third sec-
ondary objective was to analyze possible differences in
the psychological factors among patients from areas
with different impacts from the COVID-19 emergency
(North and South-Central Italy).
The answers to the questionnaire exploring “anxiety”
were summarized in synthetic indicators through the
“item response theory” technique (11–14).
Consequently, each individual was assigned a single
score for each dimension (a “COVID-19 anxiety” score,
a “general anxiety” score and a “school anxiety” score).
Statistical analysis included two steps. In the first
step, a bivariate analysis studied how the different var-
iables (taken singularly) correlated with the primary
endpoints. Depending on the nature of the covariates
and the response, we considered different statistical
tests. For ordinal categorical endpoints (trend of head-
ache and intensity of attacks), we used the Mann-
Whitney U-test, the Kruskal-Wallis test and the
Spearman’s Rho. For the numeric endpoint (frequency
of attacks), we transformed the response on the ratio
on the log scale and considered the t-test, analysis of
variance (ANOVA) and Spearman’s Rho. In the bivar-
iate analysis, each test was performed individually and
did not take into account the contemporary effect of
the other covariates.
Multivariate analysis was performed by considering
a multiple regression setting on each of the endpoints
separately. For ordinal categorial endpoints, we used a
generalized linear model (GLM) with cumulative link
and proportional odds assumption (15–19). For the
frequency ratio endpoint, we considered the Poisson
GLM with log link on the frequency reported during
the lockdown and the frequency in the 2 months before
lockdown as an offset (20–23). First, all the variables
that scored a p-value 0.2 in the bivariate analysis were
included in the model. In a second level, we further
selected the best subset of covariates through the
AIC-based (Akaike information criterion) step forward
and backward procedure. Lastly, all the non-significant
variables included in the best subset were excluded and
the remainder were used to train the final model. The
effect of variables in the multivariate analysis was rep-
resented by the coefficient bi. For trend of headache
and intensity of attacks, positive values pushed
toward improvement, while negative values toward
worsening. As for frequency of attacks, negative
values indicated a reduction (improvement), while pos-
itive values an increase (worsening). For more details
of statistical analysis, see Supplemental material).
Results
We analyzed 707 questionnaires. Demographic and
headache features and details of bivariate analysis are
reported in Table 1. On average, patients reported that
they had been in lockdown for 33 days (from 15–60
days).
How did headache go?
When the patients were asked to express a general
opinion on the “trend of the headache” during
Figure 2. Study design.
*Results concerning these variables are not discussed because they failed to show significance in multivariate analysis.
Severity: Average of headache attack frequency before lockdown and monthly consumption of drug for attacks before lockdown.
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lockdown compared to the previous 2 months, the
answers were distributed as follows: 323 patients
improved (46%), 277 remained stable (39%) and 107
worsened (15%) (Figure 3(a)). However, stable patients
were more likely to have decreased intensity or frequen-
cy of attacks rather than an increase (rho 0.73;
p< 0.0001). Regarding the intensity of the attacks,
270 patients (38%) reported that the intensity of their
headache attacks decreased, compared to the intensity
before lockdown. In 343 patients (49%) intensity was
stable, while it worsened in only 94 (13%) (Figure 3
(b)). Concerning the frequency of the attacks, patients
reported a mean of 7.38 attacks per month in the
2 months before lockdown. During lockdown, the
average monthly number of attacks dropped to 5.4
(Figure 3(c)). The t-test showed that the log ratio was
significantly lower than zero (reduction in frequency
during lockdown) with p< 0.0001 and a 95% confi-
dence interval (CI) between 0.51 and 0.39 (ratio
included between 0.60 and 0.67).
We found a significant relationship between age and
primary endpoints. In particular, the probability of
having a worsening of the trend of headache (rho
0.15; p< 0.0001), and intensity (rho 0.18; p< 0.0001)
and frequency (rho 0.2; p< 0.0001) of the attacks
increased with increasing age. Male patients presented
an increased probability of improving trend of head-
ache (p< 0.0001), and intensity (p< 0.0001) and fre-
quency (p< 0.0006) of attacks during lockdown.
Features of headache
Although our population was mostly composed of
migraine patients, the improvement in headache
observed during the lockdown involved both migraine
and tension-type headache patients without any signif-
icant difference (p> 0.05).
The average duration of headache was 39.6 32
months for the total population. We found that
patients with a longer history of headache disorders
experienced a lower improvement in the trend of head-
ache (rho 0.14; p< 0.001), and intensity (rho 0.13;
p< 0.0006) and frequency (rho 0.17; p< 0.0001) of
the attacks.
A frequency higher than 15 headaches per month in
the 2 months before the lockdown was found in 117/
707 patients (16% of the whole population) who had a
diagnosis of possible chronic headache disease. Both
the trend of headache (p> 0.05) and intensity of the
attacks (p> 0.05) during the lockdown did not
depend on whether the patient was chronic or not. In
patients with chronic headache disorders, frequency of
attacks was reduced on average by nine attacks per
month (95% CI between 7 and 11; p< 0.01).
Frequency calculated by log ratio confirmed that
chronic patients with headache disease presented a
higher improvement than episodic ones (p< 0.001).
Therapy for headache disorders
As symptomatic drugs, our patients took nonsteroidal
anti-inflammatory drugs (80%) and triptans (20%).
Patients reported that they took a mean of 4.8 symp-
tomatic drugs (range 0–30) per month prior to lock-
down. During lockdown, the monthly drug intake
dropped to 2.1 (p< 0.01).
Prophylaxis therapy was taken by 104 patients
(14%) during the lockdown period. These drugs includ-
ed amitriptyline (23/104), flunarizine (25/104), topira-
mate (21/104), valproate (5/104), and nutraceutics (30/
104). Forty-four patients (6%) had stopped prophylax-
is therapy just before lockdown (within 4 weeks). In
order to verify whether headache improvement in
patients taking prophylactic therapy could depend on
the pharmacological treatment, the primary endpoints
were compared between patients “under prophylaxis”
and “without prophylaxis” (Table 2). We did not find a
significant difference in trend of headache between the
groups (p> 0.05). This means that the subjective feeling
about one’s own headache course during lockdown did
not depend on the prophylaxis. The reduction of inten-
sity of attacks was less frequent in patients with than
without prophylaxis (24% vs. 41%), while a stable
intensity was more often reported by patients with
than without prophylaxis (47% vs. 37%) (p< 0.05).
Regarding the frequency of the attacks, we found
that there was no statistically significant difference
between patients exposed and not exposed to prophy-
laxis (0.84 vs. 1.0; p> 0.05). No relationship was
found between recently discontinuing prophylaxis and
headache worsening during lockdown (trend of head-
ache: p> 0.05; intensity of the attacks: p> 0.05; fre-
quency of the attacks: p> 0.05). We also found that
patients who underwent prophylaxis showed higher
pre-lockdown drug intake (6.7 vs. 4.5; p< 0.0001) and
fewer positive coping abilities (p< 0.05) than the
others.
Effect of psychological factors on the course of
headache disorders
Among all respondents, 88% declared that they were
taking lessons electronically. About 50% of patients
reported a reduction in school effort with the transition
from traditional school method to telematic mode. The
correlation between reduction of school effort and
improvement of the trend of headache was significant
(rho 0.15; p< 0.001). Furthermore, the reduced effort
showed a high correlation with the reduction of fre-
quency (rho 0.035; p< 0.001) and intensity (rho 0.15;
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p< 0.001) of the attacks. Regarding anxiety correlated
with telematic lessons, we found that the greater the
anxiety, the higher was the possibility of headache
worsening (trend of headache: rho 0.4, tau 0.35,
p< 0.001; frequency of attacks: rho 0.36, tau 0.36,
p< 0.001; intensity of attacks: rho 0.24, tau 0.18,
p< 0.001). Depressed mood correlated with worsening
of trend of headache (rho 0.13; p< 0.001), and intensity
(rho 0.15, tau 0.14, p< 0.001) and frequency (rho 0.04;
p< 0.001) of the attacks. We found no significant dif-
ferences in depression or anxiety score in patients from
different geographic areas (p> 0.05). We found a sig-
nificant positive correlation between general anxiety
and worsening of trend of headache (rho 0.15;
p< 0.001), and frequency (rho 0.6; p< 0.001) and
intensity (rho 0.15; p< 0.001) of the attacks. We did
not find a correlation between COVID-19 anxiety
scores and the trend of headache (rho 0.03; p> 0.05),
and intensity (rho 0.02; tau 0.01; p> 0.05) and frequen-
cy (rho 0.02; tau 0.01; p> 0.05) of the attacks. There
were no significant differences in COVID-19 anxiety
scores in patients from different geographic areas
(p> 0.05).
Twenty-three patients reported having had contact
with people who tested positive for the nasopharyngeal
swab for COVID 19. Of these, only two were family
members living together and therefore subjected to real
quarantine measures. Forty two percent of these
patients came from northern Italy, 33% from central
Italy and the remaining 25% from the south. In the
group of patients with a history of contact with
COVID-19 positive subjects we found no data in
favor of greater COVID-19 related anxiety than the
remaining population. None of the analyzed subjects
was affected by COVID 19 infection.
Multivariate analysis
Results of multivariate analysis are provided in
Figure 4 and Table 3. Reduced school effort improved
headache (p< 0.0001), while school anxiety
(p< 0.0001) and the duration of the headache
(p< 0.0001) favored headache worsening. The severity
of the headache before the lockdown was associated
with an improvement in the trend of headache and
intensity of the attacks (p< 0.0001).
Patients under prophylactic therapy showed a wors-
ening of both the trend of headache and intensity of
attacks (p< 0.05). Worsened intensity of attacks was
significantly associated with generalized anxiety
(p< 0.05), and worsened frequency of attacks with
depressed mood (p< 0.05).
Discussion
The study showed a significant improvement in the
trend of headache, and intensity and frequency of
attacks during the lockdown compared to the previous
2 months. Headache improvement was strongly corre-
lated with the reduction of school anxiety and school
effort.
The involvement of several headache centers scat-
tered throughout the country made it possible to
Figure 3. Distribution of patients according to the primary endpoints. (a) trend of headache; (b) intensity of attacks; (c) difference in
frequency of attacks between before and during lockdown.
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Table 2. Differences between patients under prophylaxis and without prophylaxis in the bivariate analysis.
Prophylactic treatment Yes 104 (15%) No 603 (85%) p-value
Mean (SD)
Age in years 13.3 (3.1) 12.4 (3.5) Ns
Number (%)
Sex Ns
Female 71 (68) 354 (59)
Male 33 (32) 249 (41)
Number (%)
Type of headache Ns
Episodic migraine without aura 41 (39) 324 (54)
Episodic migraine with aura 3 (3) 24 (4)
Tension-type headache 28 (27) 170 (28)
Chronic migraine 32 (31) 85 (14)
Number (%)
Trend of headache 38 (37) 285 (47) Ns
Improved 49 (47) 228 (38)
Stable 17 (16) 90 (15)
Worsened
Number (%)
Intensity of attacks 25 (24) 245 (41) <0.001
Lower 60 (58) 283 (47)
Stable 19 (18) 75 (12)
Higher
Number (%)
Coping ability 39 (38) 319 (53) <0.05
High 41 (39) 183 (30)
Quite 24 (23) 101 (17)
Low
Number (%)
Deflected mood Ns
Never 45 (43) 257 (43)
Sometimes 47 (45) 309 (51)
Often 12 (12) 37 (6)
Mean (SD)
Duration of headache since onset, months 44.4 (37.8) 38.7 (30.7) Ns
Mean (SD)
Number of attacks per month before lockdown 11.4 (9.25) 6.68 (6.97) <0.001
Mean (SD)
Number of attacks per month during lockdown 7.48 (7.53) 4.64 (6.53) <0.001
Mean (SD)
Number of drugs per attack intake before lockdown 6.7 (6) 4.5 (4.8) <0.001
Mean (SD)
Number of drugs per attack intake during lockdown 3.6 (4.1) 2.6 (4.3) <0.001
Mean (SD)
Severity score of headache pre-lockdown 9.18 (6.85) 5.6 (5.38) <0.001
Mean (SD)
School anxiety score 0.236 (0.7) 0.101 (0.7) Ns
Mean (SD)
General anxiety score 0.04 (0.87) 0.05 (0.8) Ns
SD: standard deviation; Ns: not significant.
Note: The p value refers to the significance of the integrated statistical analysis with which each variable (in italics) was compared between the two
groups (yes and no prophylaxis). In particular, the Mann–Whitney U test was used for nominal variables while the Chi-Square test was used for ordinal
variables. To facilitate the interpretation of significance we have added comparison of the within-group percentages in the two central columns.
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analyze questionnaire data from regions with different
COVID-19 impact. In our patients, trend of headache
was not influenced by either COVID-19 anxiety or, in
spite of the different geographic impact of the COVID-
19 emergency, the geographic origin of our patients.
Usefulness of prophylactic treatment
A very important finding of the present study is that
headache improved in both patients undergoing pro-
phylaxis and those without prophylactic drugs, thus
suggesting that the pharmacological treatment did
not impact headache course. In the multivariate anal-
ysis, we found that prophylactic treatment was even
associated with a worsened trend of headache and
intensity of attacks. However, this finding does not
mean that prophylactic drugs had a negative effect on
headache, since it is probably biased by the fact that
pharmacological prophylaxis was used in patients with
a more severe phenotype. We found that patients
adopting prophylaxis had higher pre-lockdown drug
intake (6.7 vs. 4.5; p< 0.0001) and fewer positive
coping abilities (p< 0.05), compared with those with-
out pharmacological prophylactic treatment.
The real usefulness of prophylactic drugs has been
recently challenged by a randomized controlled study,
which failed to demonstrate any superiority of either
topiramate or amitriptyline compared to placebo (24).
Our study, though not designed to investigate the effi-
cacy of pharmacological prophylaxis, underlines that
lifestyle changes related to the lockdown could explain
headache improvement in our patients more than any
prophylactic drug currently available for the pediatric
age.
Episodic vs. chronic patients
Headache improvement also involved 49% of patients
with chronic headache. More generally, the higher the
number of attacks and use of symptomatic drugs in the
2 months before the lockdown, the more the headache
improved during the lockdown. This is a surprising
result, since patients with chronic headache disorders
are usually characterized by worse outcome, greater
risk of disability, drug resistance and drug abuse (25).
Since the determinant that mostly explained headache
improvement in our patients was the reduction in
school effort and anxiety, the hypothesis can be made
that, in turn, anxiety related to school, which is known
to increase after the Christmas holidays (4,26), could
have contributed to headache severity during the pre-
lockdown period (January and February). Studies have
shown that the frequency of migraine attacks correlates
with the amount of homework and the timing of exami-
nations (27,28). Children with migraine disease have a
high rate of school absenteeism, limited extracurricular
activities, and difficulties in interpersonal relationships
with their peers (29). Other factors, such as loss of lei-
sure time, changes in sleep, and other socio-
environmental factors can exert a negative effect on
children’s headache during winter (30,31).
Psychological determinants of headache
improvement
In our study, the change in school modalities due to the
lockdown played a decisive role in explaining the mod-
ification of our patients’ headache disorders. Most of
our patients reported a reduction in school effort,
although the school had not stopped, but they were
required only to attend telematic lessons. It is to be
underlined that in the middle of the lockdown the
Public Instruction Minister maintained that all stu-
dents would be admitted to their next class, thus ensur-
ing them a reward independent of their efforts.
Interestingly, the patients who showed headache dis-
ease worsening during the lockdown were those who
kept feeling school stress.
Other psychological factors correlated with head-
ache disorder changes during the lockdown.
Generalized anxiety was strongly associated with an
increase in both intensity and frequency of the attacks.
Although only 7% of the population reported feeling
sad, depressed mood correlated with a worsened fre-
quency of attacks. Comorbidity between childhood
migraine and psychiatric disorders has been studied
extensively (32–34). Depression is one of the most
common psychiatric comorbidities in patients with
migraine, the relationship between migraine and
depression being bidirectional (35). In patients with
migraine disease, depression is a significant predictor
of migraine evolution into chronic migraine disorder
(36). Furthermore, people with migraine disease who
have experienced depression are more likely to be
refractory to migraine treatments and to develop med-
ication adaptation headache and disability (37,38). As
suggested by several studies, anxiety may be a precip-
itating factor that increases risk for headaches
(33,34,39). Additionally, research suggests that some
children may be less able to cope with daily life stres-
sors, resulting in an increased number and severity of
headaches (40). The association between anxiety and
headache disorders could be bidirectional. In children
with recurrent headaches, the level of anxiety increases
from childhood to adolescence, and a history of head-
ache diseases during childhood increases the risk for
anxiety disorders in early adulthood (41).
The results of our study and the improvement in
headache seem almost to contrast with the catastrophic
and negative atmosphere of the lockdown. Although
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Figure 4. Results from multivariate analysis. Relations between frequency log ratio and severity score (a), duration of headache in
months (b), school anxiety (c) and reduction of school effort (d).
Table 3. Results of multivariate analysis. Referring to trend of headache and intensity of the attacks, the model intercepts as standard
the patients with mean severity and duration of headache, mean school stress and anxiety, no reduction of school effort and without
prophylactic drugs. Negative values of coefficients on the log scale (between 0 and 1 on the standard scale) correspond to worsening
effect of the variable on the endpoint. Positive values correspond to improvement of the endpoints. Referring to frequency of attacks,
we considered the ratio between the monthly rate of attacks observed during the lockdown and the baseline (2 months before the
lockdown). Negative values correspond to a reducing effect of the variable on the endpoint, while positive values correspond to an
increasing effect of the variable on frequency of the attacks.
Primary endpoint (Significant variable) Results (b-value standard error) eb Significance
Trend of headache (improved, stable, worsened)
Effect of covariates
– Severity 0.077 0.015 1.08 <0.001
– Duration of headache 0.008 0.002 0.993 <0.001
– Prophylactic treatment 0.548 0.217 0.578 0.010
– Reduction of school effort 1.275 0.159 3.58 <0.001
– School anxiety 1.241 0.118 0.289 <0.001
Intensity of the attacks (reduced, stable, increased)
Effect of covariates
– Duration of headache 0.006 0.002 0.994 0.022
– Prophylactic treatment 0.677 0.212 0.508 0.001
– Reduction of school effort 1.403 0.161 4.066 <0.001
– School anxiety 0.848 0.113 0.428 0.008
– General anxiety 0.257 0.097 0.774 <0.001
Frequency of the attacks for month (ratio during/before lockdown)
Effect of covariates
– Severity 0.027 0.002 0.973 <0.001
– Duration of headache 0.001 0.001 1.001 0.012
– Reduction of school effort 0.557 0.036 0.573 <0.001
– School anxiety 0.342 0.024 1.408 <0.001
– Depressed mood 0.078 0.037 0.925 0.035
– Age 0.033 0.006 1.034 <0.001
– Male sex 0.104 0.039 0.901 0.008
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our work underlines how lifestyle changes have influ-
enced the improvement in headache, other dynamics
should also be considered over a longer observation
period. In particular, a mechanism that could be
involved is resilience, which in several works has been
described as decisive for overcoming the difficulties of
the lockdown and other catastrophic events and seems
to also play a role in the processing of chronic pain
(42,43). Resilience is a dynamic and multidimensional
construct related to the interactions between individu-
als and the different environments in which they are
experienced (family, peers, school, community and
society) (43). Although we did not find correlation
between the improvement of headache and emotional
impact of the pandemic, we also could not exclude a
role of resilient behavior in the management of stress
caused by the lockdown.
Limitations of the study
Our study has some limitations. First, all the analyzed
variables were collected through a questionnaire, thus
they were less verifiable then data issued from medical
records. Although methods for verifying the reliability
of the answers have been adopted, we cannot complete-
ly exclude that the parents did not answer the ques-
tions, even partially, instead of the patients. However,
this also reflects clinical practice where, for younger
children, even the notations in the diary of headaches
and the taking of drugs are recorded by the parents and
not directly by the patient. The questionnaire method
also implies the limitation of a retrospective analysis of
the data collected. Second, in our population, chronic
patients and patients undergone prophylaxis repre-
sented only a small part of the whole sample. Third,
there were considerably fewer patients living in north-
ern Italy than those in the other parts of Italy. Fourth,
the results of our study must be interpreted within a
first phase of the lockdown when we still had little
information available on either the disease or the dura-
tion of the measures. Some effects of the lockdown (for
example economic and financial ones) were not yet
imaginable. Our data must therefore be interpreted in
that precise time period. In addition, it was not a pur-
pose of this study to verify a possible direct pathogenic
role of the COVID-19 infection on the onset or course
of the headache. Neurological symptoms have been
reported during COVID-19 disease (44), including
potentially fatal ones. Headache has been reported in
the course of COVID-19 infection, but at present there
is no definite evidence of a role of the virus in the gen-
esis of headache.
Conclusions
The lockdown state allowed us to study how lifestyle
changes could affect the course of headache in a large
population of children and adolescents scattered across
our country. The most important result was that during
the lockdown there was a significant improvement in
the subjective trend of headache, and a reduction in the
intensity and frequency of the attacks. What mostly
explained the headache improvement was the reduction
of stress related to school. The improvement was inde-
pendent of geographic area of origin and pharmacolog-
ical prophylaxis. All these elements suggest that in
children and adolescents, lifestyle is a strong determi-
nant of headache course. This should be taken into
account when proposing any treatment for migraine
and tension-type headache, letting the patient and
her/his parents be aware that any intervention on
stress factors is more likely to be effective than the
currently available drugs.
Clinical implications
• During the lockdown, the change in lifestyle and in particular the reduction of school stress led to a
significant improvement in headache.
• The improvement in headache has also affected people with chronic headache who may have greater drug
resistance.
• The improvement occurred independently of the use of prophylaxis therapy.
• The intervention in lifestyle and stress management represented fundamental elements for the management
of headache in children.
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